PGNX

Progenics Pharmaceuticals Inc. News Headlines

$7.24
*  
0.25
3.58%
Get PGNX Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading PGNX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is This the Top for Progenics Pharmaceuticals, Inc. (PGNX)? - Tale of the Tape
1/14/2014 7:15:01 AM - Zacks.com


Progenics Likely To Announce Positive Prostate Cancer Data In January
1/7/2014 8:00:00 AM - Seeking Alpha


Small Cap BioPharmas With Near-Term Catalysts
1/3/2014 7:55:00 AM - Seeking Alpha


These Small-Cap BioPharma Companies Have Catalysts Upcoming
12/23/2013 8:59:00 AM - Seeking Alpha


Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond
12/19/2013 8:01:00 AM - Seeking Alpha


Healthcare Stocks Still Holding Slim Gains; Progenics Pharma Adds 4% After Re-Starting Azedra Study
11/25/2013 3:56:23 PM - MT Newswires


Sector Update: Healthcare
11/25/2013 3:52:17 PM - MT Newswires


Narrower Q3 Loss at Progenics - Analyst Blog
11/14/2013 9:50:01 AM - Zacks.com


Company news for November 13, 2013 - Corporate Summary
11/13/2013 10:06:01 AM - Zacks.com


Company news for November 12, 2013 - Corporate Summary
11/12/2013 10:06:01 AM - Zacks.com


Sector Update: Healthcare Shares Mixed Pre-Market; Progenics Reports Better-Than-Expected Net Loss
11/11/2013 8:53:18 AM - MT Newswires


Sector Update: Healthcare
11/11/2013 8:39:10 AM - MT Newswires


Pre-Market Earnings Report for November 11, 2013 : SLW, HBM, ABFS, PGNX, STRL, CRNT, RDNT, BTN, CTIB
11/8/2013 4:00:07 PM - NASDAQ.com News


Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog
11/8/2013 11:06:08 AM - Zacks.com


Progenics Pharmaceutics Upcoming Catalyst And Big Increase In Institutional Ownership Make It A Buy Now For 2014
11/5/2013 3:46:00 AM - Seeking Alpha


Salix Pharmaceuticals Thrives With Promising GI Drugs
11/4/2013 1:00:00 PM - Investor's Business Daily


Update on Progenics Pharma's Relistor - Analyst Blog
10/3/2013 6:06:10 PM - Zacks.com


Progenics Pharmaceuticals - Alive Again With Institutional Backing?
8/26/2013 3:05:00 PM - Seeking Alpha


Progenics' Loss Narrows Y/Y - Analyst Blog
8/15/2013 8:31:16 AM - Zacks.com


Salix Misses on 2Q Earnings - Analyst Blog
8/14/2013 10:20:01 AM - Zacks.com


Progenics Pharmaceuticals, Inc Enters Oversold Territory - Tale of the Tape
8/13/2013 2:43:01 AM - Zacks.com


Sector Update: Healthcare Shares Lower; Progenix Narrows Q2 Net Loss
8/9/2013 7:10:31 AM - MT Newswires


Sector Update: Healthcare
8/9/2013 7:09:39 AM - MT Newswires


Can the Recent Uptrend Continue for Progenics Pharmaceuticals, Inc. (PGNX)? - Tale of the Tape
7/26/2013 4:57:01 AM - Zacks.com


Milestone Payment for Sucampo - Analyst Blog
7/2/2013 5:38:21 PM - Zacks.com